Myeloid Therapeutics, a company developing in vivo cell therapies for cancer as well as a novel gene editing technology, has ...

Merck licenses Cyprumed's oral drug delivery platform in $493M deal to develop oral peptide formulations, potentially for GLP-1 drugs.

Tariffs on pharmaceutical products that President Donald Trump has teased for weeks are one step closer to fruition after the ...

The centerpiece of Bristol Myers Squibb’s $13 billion MyoKardia acquisition failed a Phase 3 study meant to expand the ...

A panel of experts who decide the national immunization schedule will meet on Tuesday for the first time in 2025, providing ...

The government is fighting in court for a plan to cut spending on overhead research costs for grantees. Primate centers fear ...

Duality Biologics, a Chinese antibody-drug conjugates startup, to go public on Hong Kong Stock Exchange with $194M IPO amid ...

Ab­b­Vie and San­doz have re­solved their patent dis­pute over Ab­b­Vie’s block­buster im­munol­o­gy drug Rin­voq. San­doz ...

The American Medical Association is urging Optum, a unit of UnitedHealth Group, to ease up on recouping the loans it provided ...

After accumulating $86 billion in global sales, Amgen is still trying to keep Enbrel biosimilars off the market, Sandoz ...

Pfizer discontinues obesity pill danuglipron after potential drug-induced liver injury in trial patient; company has GIP ...

Commerce Secretary Howard Lutnick has indicated more specific timelines as to when pharma tariffs could surface, noting they ...